| Dual drug delivery of trapoxin A and methotrexate from biocompatible PLGA-PEG polymeric nanoparticles enhanced antitumor activity in breast cancer cell line E Akbari, H Mousazadeh, Z Sabet, T Fattahi, A Dehnad, A Akbarzadeh, ... Journal of Drug Delivery Science and Technology 61, 102294, 2021 | 40 | 2021 |
| Biotechnological applications of nanomaterials for air pollution and water/wastewater treatment Y Panahi, H Mellatyar, M Farshbaf, Z Sabet, T Fattahi, A Akbarzadehe Materials Today: Proceedings 5 (7), 15550-15558, 2018 | 40 | 2018 |
| Sonidegib potentiates the cancer cells’ sensitivity to cytostatic agents by functional inhibition of ABCB1 and ABCG2 in vitro and ex vivo Y Zhang, D Vagiannis, Y Budagaga, Z Sabet, I Hanke, T Rozkoš, ... Biochemical Pharmacology 199, 115009, 2022 | 16 | 2022 |
| Talazoparib does not interact with ABCB1 transporter or cytochrome P450s, but modulates multidrug resistance mediated by ABCC1 and ABCG2: an in vitro and ex vivo study Z Sabet, D Vagiannis, Y Budagaga, Y Zhang, E Novotná, I Hanke, ... International Journal of Molecular Sciences 23 (22), 14338, 2022 | 9 | 2022 |
| Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo Y Budagaga, Z Sabet, Y Zhang, E Novotná, I Hanke, T Rozkoš, J Hofman Biochemical Pharmacology 216, 115769, 2023 | 6 | 2023 |
| Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo Y Zhang, D Vagiannis, Y Budagaga, Z Sabet, I Hanke, T Rozkoš, ... Pharmaceutics 14 (12), 2595, 2022 | 3 | 2022 |
